Skip to main content
Top

Calcified Tissue International

Issue 6/2008

Content (8 Articles)

Editorial

Redefining Osteoporosis

B. E. Christopher Nordin

Assessment of Clinical Risk Factors to Validate the Probability of Osteoporosis and Subsequent Fractures in Korean Women

Yoo Mee Kim, Noo-Rie Hyun, Ho-Sang Shon, Hae-Soon Kim, So-Young Park, Il-Hyung Park, Yoon-Sok Chung, Hong-Geun Jung, Do-Hee Kim, Sung-Kil Lim

Physical Activity and Bone Turnover Markers: A Cross-Sectional and a Longitudinal Study

Silvano Adami, Davide Gatti, Ombretta Viapiana, Carmelo Erio Fiore, Ranuccio Nuti, Giovanni Luisetto, Marco Ponte, Maurizio Rossini

Bone Parameters are Improved with Intermittent Dosing of Vitamin D3 and Calcitonin

C. J. Andresen, M. Moalli, C. H. Turner, E. Berryman, R. Pero, C. M. Bagi

Vitamin D Receptor Gene Polymorphisms Predict Acquired Resistance to Clodronate Treatment in Patients with Paget’s Disease of Bone

Giuseppe Mossetti, Luigi Gennari, Domenico Rendina, Gianpaolo De Filippo, Daniela Merlotti, Vincenzo De Paola, Pina Fusco, Teresa Esposito, Fernando Gianfrancesco, Giuseppe Martini, Ranuccio Nuti, Pasquale Strazzullo

Characterization of the Bone Phenotype in ClC-7-Deficient Mice

Anita Vibsig Neutzsky-Wulff, Morten A. Karsdal, Kim Henriksen

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine